Vascular Discovery 2026 Scientific Sessions  /  03. Concurrent Session 1a: Thrombosis, Hemostasis, and Lymphatic Biology  /  Rethinking Factor V: An Anticoagulant of the Extrinsic Pathway
Logo

American Heart Association

  28
  0

Final ID:

Rethinking Factor V: An Anticoagulant of the Extrinsic Pathway

  • Jewell, Megan  ( University of Colorado Anschutz Medical Campus , Denver , Colorado , United States )
    • Author Disclosures:
    Megan Jewell: No Answer
Meeting Info:

Vascular Discovery 2026 Scientific Sessions

2026

Bellevue, Washington

Session Info:

03. Concurrent Session 1a: Thrombosis, Hemostasis, and Lymphatic Biology

Thursday, 05/14/2026 , 10:30AM - 12:00PM

Oral

More abstracts on this topic:
VAMP8 Deficiency Attenuates Atherosclerosis Through Impaired Platelet Secretion and Hepatic Lipid Remodeling

Mohammadmoradi Shayan, Driehaus Elizabeth, Dunn Emily, Alfar Hammodah, Voy Clairity, Dong Brittany, Joshi Smita, Gordon Scott, Whiteheart Sidney

Targeting mitochondrial calcium uniporter attenuates platelet hyperactivation and procoagulant phenotype associated with obesity in humans and mice

Ghatge Madankumar, Flora Gagan, Kumskova Mariia, Nayak Manasa, Hsieh Pedro, Correia Marcelo, Chauhan Anil

You have to be authorized to contact abstract author. Please, Login
Not Available